KFS
TCRT icon

KMS Financial Services’s Alaunos Therapeutics TCRT Stock Holding History

KMS Financial Services’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$63K Hold
159
– – 0.01% 529
2014
Q2 		$96K Buy
159
+26
+20% +$14.5K 0.01% 528
2014
Q1 		$92K Hold
133
– – 0.01% 515
2013
Q4 		$87K Hold
133
– – 0.01% 511
2013
Q3 		$79K Buy
+133
New +$59.9K 0.02% 432

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KMS Financial Services's TCRT Position: Q3 2014 in Review

KMS Financial Services held its Alaunos Therapeutics (TCRT) position steady in Q3 2014 at 159 shares worth $63K. The position accounts for 0.01% of the portfolio, ranked #529.

KMS Financial Services first reported a position in TCRT in Q3 2013 and has held it in 5 quarters since. The position peaked at $96K in Q2 2014. 94 funds tracked by Wall St. Rank hold TCRT as of Q3 2014.

  • KMS Financial Services held 159 shares of Alaunos Therapeutics worth $63K as of Q3 2014.
  • KMS Financial Services left its Alaunos Therapeutics share count unchanged in Q3 2014.
  • Alaunos Therapeutics made up 0.01% of KMS Financial Services's portfolio in Q3 2014, its #529 holding.
  • KMS Financial Services first reported a position in Alaunos Therapeutics in Q3 2013 and has held it in 5 quarters since.
  • KMS Financial Services's Alaunos Therapeutics position peaked at $96K in Q2 2014.
  • 94 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2014.

Based on KMS Financial Services's 13F filing for Q3 2014, filed 14 Nov 2014.